There are currently zero authorized or approved preventative COVID therapies in the U.S. but Canadian biotech SaNOtize wants to change that, charting plans to move a nasal spray into a phase 3 study as soon as October.
Read more here.
There are currently zero authorized or approved preventative COVID therapies in the U.S. but Canadian biotech SaNOtize wants to change that, charting plans to move a nasal spray into a phase 3 study as soon as October.
Read more here.
![[Plenty in Sustainable Brands] This startup is determined to provide ‘Plenty’ of jobs and leafy greens all year round](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
